Sharon Lam

1.9k total citations
16 papers, 506 citations indexed

About

Sharon Lam is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Sharon Lam has authored 16 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Sharon Lam's work include Cytomegalovirus and herpesvirus research (7 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Sharon Lam is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Sharon Lam collaborates with scholars based in United States, China and Switzerland. Sharon Lam's co-authors include Catherine M. Bollard, Cliona M. Rooney, Nancie M. Archin, Julia Sung, Carolina Garrido, David M. Margolis, Carolina Colli Cruz, Elizabeth J. Shpall, Patrick J. Hanley and Suping Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Sharon Lam

16 papers receiving 498 citations

Peers

Sharon Lam

ONCOL

IMMUN

EPIDE

VIROL

Béatrice Corre France

Lee Adam Wheeler United States

Nithianandan Selliah United States

Catalina Martínez Colombia

Felix G. Hermann Germany

Lukas Klein Germany

Katsuyoshi Habiro Japan

Bharat Bajaj United States

David Bockstoce United States

Yannick Bulliard United States

Béatrice Corre France

Sharon Lam

252 ×1.2

ONCOL

340 ×2.0

IMMUN

174 ×1.2

53 ×0.4

EPIDE

93 ×0.7

VIROL

Citations per year, relative to Sharon Lam Sharon Lam (= 1×) peers Béatrice Corre

Countries citing papers authored by Sharon Lam

Since Specialization

Citations

This map shows the geographic impact of Sharon Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Lam more than expected).

Fields of papers citing papers by Sharon Lam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Lam. The network helps show where Sharon Lam may publish in the future.

Co-authorship network of co-authors of Sharon Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Lam. A scholar is included among the top collaborators of Sharon Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Lam. Sharon Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Xia, Wenhao, Aditya Reddy Kolli, Arkadiusz K. Kuczaj, et al.. (2024). Aerosol delivery and spatiotemporal tissue distribution of hydroxychloroquine in rat lung. European Journal of Pharmaceutical Sciences. 194. 106693–106693. 1 indexed citations

Cattaruzza, Fiore, Milton To, Caitlin Koski, et al.. (2023). Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors. Nature Cancer. 4(4). 485–501. 50 indexed citations

To, Milton, Michael Fox, Fiore Cattaruzza, et al.. (2021). Abstract P193: AMX-818, a novel prodrug HER2-XPAT T-cell engager (TCE) with potent T cell activation, proteolytic cleavage and efficacy in xenograft tumors, and wide safety margins in NHP (Non Human Primate). Molecular Cancer Therapeutics. 20(12_Supplement). P193–P193. 4 indexed citations

Cattaruzza, Fiore, Caitlin Koski, Milton To, et al.. (2021). Abstract 1824: HER2-XPAT, a novel protease-activatable T-cell engager (TCE) with potent T-cell activation and efficacy in solid tumors and large safety margins in non-human primate (NHP). Cancer Research. 81(13_Supplement). 1824–1824. 1 indexed citations

Prussak, Charles, Sharon Lam, Jieyu Zhang, et al.. (2020). Preclinical evaluation of anti-ROR1 CAR T cells employing a ROR1 binding SCFV derived from the clinical stage mab cirmtuzumab.. Journal of Clinical Oncology. 38(5_suppl). 41–41. 2 indexed citations

Hasan, Md Kamrul, George F. Widhopf, Suping Zhang, et al.. (2019). Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis. npj Breast Cancer. 5(1). 35–35. 24 indexed citations

Zhang, Suping, Han Zhang, Emanuela M. Ghia, et al.. (2019). Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody. Proceedings of the National Academy of Sciences. 116(4). 1370–1377. 113 indexed citations

Patel, Shabnum, Sharon Lam, Carolina Colli Cruz, et al.. (2017). HIV-Specific T CELLS Expanded from HIV+ and HIV-Naive Donors Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT. Biology of Blood and Marrow Transplantation. 23(3). S194–S195. 1 indexed citations

Patel, Shabnum, et al.. (2015). Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Naïve Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(3). 536–541. 33 indexed citations

10.

Sung, Julia, Sharon Lam, Carolina Garrido, et al.. (2015). Expanded Cytotoxic T-cell Lymphocytes Target the Latent HIV Reservoir. The Journal of Infectious Diseases. 212(2). 258–263. 73 indexed citations

11.

Hanley, Patrick J., J. Joseph Melenhorst, Sarah Nikiforow, et al.. (2015). CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Science Translational Medicine. 7(285). 285ra63–285ra63. 95 indexed citations

12.

Lam, Sharon, Julia Sung, Carolina Colli Cruz, et al.. (2014). Broadly-specific Cytotoxic T Cells Targeting Multiple HIV Antigens Are Expanded From HIV+ Patients: Implications for Immunotherapy. Molecular Therapy. 23(2). 387–395. 40 indexed citations

13.

Hanley, Patrick J., Caridad Martinez, Sharon Lam, et al.. (2013). Improving immune reconstitution after cord blood transplantation using ex vivo expanded virus-specific T cells: a phase I clinical study. Cytotherapy. 15(4). S21–S21. 3 indexed citations

14.

Lam, Sharon & Catherine M. Bollard. (2013). T-cell Therapies for HIV. Immunotherapy. 5(4). 407–414. 38 indexed citations

15.

Cruz, Carolina Colli, Sharon Lam, Patrick J. Hanley, et al.. (2013). Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy. Clinical & Experimental Immunology. 174(1). 89–96. 7 indexed citations

16.

Hanley, Patrick J., Sharon Lam, Elizabeth J. Shpall, & Catherine M. Bollard. (2012). Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus. Journal of Visualized Experiments. e3627–e3627. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact